Alvogen Companies Donate To Support COVID Vaccines
As Hikma Contributes $4m To Address Unmet Healthcare Needs
Executive Summary
Alvogen and sister company Alvotech have donated to UNICEF to support vaccine supply to over 90 low-and-middle-income countries, while Hikma has also made a multi-million-dollar donation. India’s Dr Reddy’s is moving ahead with the Sputnik V vaccine, while AstraZeneca is partnering with Insud Pharma on its vaccine in Spain. Meanwhile, the UK government has extended its vaccination contract with Wockhardt.
You may also be interested in...
Dr Reddy’s Accelerates Vaccine Efforts
Dr Reddy’s is collaborating with the Indian government’s biotechnology department to conduct Sputnik V vaccine clinical trials In India, after it received approval from the DCGI. Pfizer’s CEO has offered an update on the development and distribution of the COVID-19 vaccine that it is developing in partnership with BioNTech. Cipla has launched COVID-19 antibody detection kits for India. And the WHO has called for management of the coronavirus “infodemic.”
Biosimilar Education And Innovation Bills Head To Biden’s Desk
The Advancing Education on Biosimilars Act and the Ensuring Innovation Act will be looked at by the US President Joe Biden, after receiving the approval of both the Senate and the House of Representatives. The bills are aimed at lowering prescription drug costs and saving overall healthcare costs.
Aurobindo’s Latest Launches Include Truvada And Atripla Rivals
Aurobindo has announced the launch of generic versions of Truvada, Atripla, Minocin and Gleevec in the US. As its generics business grows in the US, Europe, Canada and the rest of the world markets, Aurobindo plans to establish itself in China. The Indian pharma company has also announced its plan to commission new facilities to serve the external market.